Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
02 2019
Historique:
received: 10 08 2018
revised: 27 09 2018
accepted: 04 10 2018
pubmed: 20 10 2018
medline: 16 11 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

Adenomyomatous polyps (APs) of the uterus (also termed polypoid adenomyomas and pedunculated adenomyomas) are exophytic proliferations composed of myomatous stroma admixed with endometrial glands. APs can be diagnostically challenging, mimicking polypoid neoplasms such as atypical polypoid adenomyoma and adenosarcoma. The purpose of this study was to describe the clinicopathological, morphologic, and molecular features of APs, as well as to raise awareness of this entity as a potential source of diagnostic confusion. We identified APs diagnosed at Brigham and Women's Hospital from 2000 to 2015. We reviewed histologic slides and obtained archival tissue for immunohistochemical and molecular studies. APs seen in consultation were associated with a broad differential, including adenosarcoma, atypical polypoid adenomyoma, and endometrial neoplasia. We performed a histologic review of 84 APs diagnosed at our institution and identified 2 distinct morphologic types of APs, which we have termed type 1 (with vaguely fascicular myomatous stroma intimately admixed with glands) and type 2 (containing a well-defined stalk of smooth muscle entrapping glands). Most APs exhibited CD10-positive (100%; 72/72) and desmin-positive (97%; 70/72) stroma. Diffuse caldesmon positivity was present in 97% (28/29) of type 2 polyps compared with 8% (3/39) of type 1 APs. APs did not harbor mutations in exon 2 of MED12. APs are not uncommon in routine practice and may be misinterpreted as more worrisome lesions. We identified 2 types of APs with distinct morphology and immunophenotype. The absence of MED12 exon 2 mutations suggests that the pathogenesis of APs is separate from uterine leiomyomas.

Identifiants

pubmed: 30339971
pii: S0046-8177(18)30388-5
doi: 10.1016/j.humpath.2018.10.002
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
MED12 protein, human 0
Mediator Complex 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-245

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Kyle C Strickland (KC)

Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: kyle.strickland@duke.edu.

Liping Yuan (L)

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: lyuan1@bwh.harvard.edu.

Bradley J Quade (BJ)

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: bquade@bwh.harvard.edu.

Marisa R Nucci (MR)

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: mnucci@bwh.harvard.edu.

Brooke E Howitt (BE)

Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA. Electronic address: bhowitt@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH